CR2 Polyclonal Antibody

$Raji cells probed with \\tCD21\/EBV receptor Polyclonal Antibody, Unconjugated (bs-3792R) at 1:20 for 30 minutes followed by incubation with a conjugated secondary (PE Conjugated) (green) for 30 minutes compared to control cells (blue), secondary only (light blue) and isotype control (orange).$

Raji cells probed with \\tCD21\/EBV receptor Polyclonal Antibody, Unconjugated (bs-3792R) at 1:20 for 30 minutes followed by incubation with a conjugated secondary (PE Conjugated) (green) for 30 minutes compared to control cells (blue), secondary only (light blue) and isotype control (orange).

Raji lysates probed with CD21 Polyclonal Antibody, Unconjugated (bs-3792R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.

Applications

WB
ELISA
FCM
IHC-P

Reactivity

Human
Rat

Predicted Reactivity

Mouse

Overview
Catalog #	bs-3792R
Product Name	CR2 Polyclonal Antibody
Applications	WB, ELISA, FCM, IHC-P
Reactivity	Human, Rat
Predicted Reactivity	Mouse
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human CR2
Immunogen Range	981-1092/1092
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	1380
Swiss Prot	P20023
Subcellular location	Cell membrane
Synonyms	CR; C3DR; CD21; CVID7; SLEB9; Complement receptor type 2; Cr2; Complement C3d receptor; Epstein-Barr virus receptor; EBV receptor
Background	Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRPU. Participates in B lymphocytes activation.
Application Dilution
WB	1:300-5000
ELISA	1:500-1000
FCM	1:20-100
IHC-P	1:200-400